data_1svr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1svr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 . . . . . 2 N--CA 1.298 -8.067 1 N-CA-C 91.558 -7.201 . . . . 6.32 91.558 . . . . . . . . . 2 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.597 ' HB3' ' CA ' ' A' ' 195' ' ' GLY 0.298 3.7 m-85 -84.81 157.12 21.06 Favored 'General case' 3 C--N 1.126 -9.132 1 N-CA-C 99.492 -4.262 . . . . 6.55 99.492 -170.619 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -105.02 115.99 61.43 Favored Pre-proline 3 C--N 1.166 -7.389 0 CA-C-N 110.673 -2.967 . . . . 6.4 104.013 -173.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.548 ' HA ' ' O ' ' A' ' 193' ' ' ASP . 30.6 Cg_endo -68.13 161.11 45.84 Favored 'Trans proline' 2 N--CA 1.373 -5.597 0 N-CA-C 102.704 -3.614 . . . . 3.46 102.704 -178.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.468 ' O ' HD23 ' A' ' 163' ' ' LEU . 6.0 mtp180 -147.64 144.97 28.78 Favored 'General case' 1 C--N 1.236 -4.33 0 N-CA-C 105.567 -2.012 . . . . 4.74 105.567 -178.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.895 ' HG ' ' HA ' ' A' ' 179' ' ' LEU . 3.4 mm? -113.96 104.6 12.32 Favored 'General case' 0 C--N 1.268 -2.942 0 C-N-CA 118.28 -1.368 . . . . 3.07 108.366 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.82 HD21 ' HA ' ' A' ' 176' ' ' GLU . 2.2 tm? -98.87 138.7 35.62 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 104.764 -2.31 . . . . 2.75 104.764 177.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . 0.66 ' CB ' HG13 ' A' ' 177' ' ' VAL . 21.5 t-160 -119.93 135.74 54.78 Favored 'General case' 0 C--N 1.282 -2.333 0 C-N-CA 120.131 -0.628 . . . . 2.25 110.355 -176.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.769 HD13 HD13 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -121.37 96.81 4.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.041 -1.096 . . . . 2.24 108.041 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.679 ' CB ' ' CB ' ' A' ' 188' ' ' ASP . 4.4 p -179.45 170.62 1.33 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 123.274 1.511 . . . . 2.43 113.257 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.467 ' O ' ' C ' ' A' ' 169' ' ' ASP . . . 166.25 47.16 0.02 OUTLIER Glycine 0 C--N 1.281 -2.483 0 N-CA-C 109.743 -1.343 . . . . 3.15 109.743 176.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 168' ' ' GLY . 54.3 m-20 41.99 -121.08 0.54 Allowed 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 119.498 1.649 . . . . 3.45 107.268 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.21 -23.26 28.36 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.321 -0.951 . . . . 5.53 111.623 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.565 ' O ' ' HG2' ' A' ' 173' ' ' LYS . 4.2 t-20 -96.06 74.78 3.03 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.567 -2.012 . . . . 4.71 105.567 176.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.938 ' HB3' ' HB3' ' A' ' 209' ' ' GLN . . . -60.34 135.38 57.72 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 122.174 0.988 . . . . 3.27 109.458 -177.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.589 ' HG2' ' C ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -153.67 139.03 17.58 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 104.891 -2.263 . . . . 4.82 104.891 -177.379 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.739 HG13 ' HG2' ' A' ' 213' ' ' LYS . 1.5 p -131.12 151.24 35.51 Favored 'Isoleucine or valine' 1 C--N 1.233 -4.485 0 N-CA-C 107.074 -1.454 . . . . 2.9 107.074 -176.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.586 ' C ' HD23 ' A' ' 164' ' ' LEU . . . -177.31 164.23 2.13 Favored 'General case' 0 C--N 1.275 -2.637 0 C-N-CA 118.7 -1.2 . . . . 3.11 110.685 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.82 ' HA ' HD21 ' A' ' 164' ' ' LEU . 35.5 tt0 -60.55 147.4 41.64 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.71 0.766 . . . . 3.75 109.174 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.66 HG13 ' CB ' ' A' ' 165' ' ' HIS . 0.5 OUTLIER -146.89 155.24 47.84 Favored Pre-proline 0 C--N 1.285 -2.214 0 N-CA-C 108.299 -1.0 . . . . 3.14 108.299 179.773 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.619 ' O ' HG21 ' A' ' 177' ' ' VAL . 29.9 Cg_endo -71.76 175.65 9.34 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.388 2.059 . . . . 3.17 108.208 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.895 ' HA ' ' HG ' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -54.86 143.19 26.63 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.564 -1.335 . . . . 4.56 108.825 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.784 ' N ' HD13 ' A' ' 179' ' ' LEU . . . -165.34 95.72 0.66 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.392 -1.323 . . . . 3.27 111.817 175.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.907 HG23 ' HA3' ' A' ' 250' ' ' GLY . 0.2 OUTLIER -90.6 -50.96 5.63 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 105.233 -2.136 . . . . 3.84 105.233 176.246 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.5 -52.37 32.96 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.805 1.242 . . . . 3.33 109.902 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.562 ' HB3' ' HB3' ' A' ' 180' ' ' ALA . 41.7 t -75.59 7.48 3.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.708 -0.62 . . . . 2.97 110.431 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.614 HD12 ' HZ ' ' A' ' 245' ' ' PHE . 0.3 OUTLIER -55.01 -176.36 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.703 1.138 . . . . 2.25 108.857 179.242 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.594 ' ND2' ' NE2' ' A' ' 165' ' ' HIS . 1.5 p-10 -141.3 78.68 1.65 Allowed 'General case' 0 C--N 1.27 -2.851 0 N-CA-C 107.917 -1.142 . . . . 2.46 107.917 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 39.9 t -55.04 141.29 34.82 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 106.785 -1.561 . . . . 2.18 106.785 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.938 ' CA ' ' HB2' ' A' ' 205' ' ' LYS . . . 106.88 -33.69 6.24 Favored Glycine 1 C--O 1.141 -5.673 0 CA-C-O 117.625 -1.653 . . . . 2.09 109.258 -178.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.736 ' HA ' ' OG ' ' A' ' 206' ' ' SER . 0.1 OUTLIER -105.16 173.37 6.33 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 121.366 2.583 . . . . 2.22 108.045 177.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' CYS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 202' ' ' ASN . 7.5 m -87.85 142.58 27.7 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 117.152 -1.819 . . . . 1.42 107.209 -175.436 -84.611 4.406 -152.368 116.264 2.062 110.35 114.616 -127.066 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.477 ' CD1' ' O ' ' A' ' 164' ' ' LEU . 1.7 t80 -131.97 158.09 42.37 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.69 0.757 . . . . 2.58 108.97 -176.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 1.3 tp -144.0 118.13 9.5 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.11 -0.7 . . . . 2.14 109.11 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.666 ' C ' ' CD1' ' A' ' 192' ' ' LEU . 0.2 OUTLIER -109.95 137.59 47.51 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.455 -2.054 . . . . 2.57 105.455 174.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.61 ' HA ' HG13 ' A' ' 198' ' ' ILE . 26.5 t0 -107.68 131.64 54.19 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.514 -1.291 . . . . 3.06 107.514 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -135.21 98.16 3.91 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.818 -0.808 . . . . 2.98 108.818 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.597 ' CA ' ' HB3' ' A' ' 159' ' ' TYR . . . 49.18 -108.18 0.39 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.852 -1.299 . . . . 3.41 109.852 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.528 ' O ' ' CB ' ' A' ' 229' ' ' PRO . 12.2 mt -93.32 -23.11 18.59 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 122.212 -0.581 . . . . 4.07 111.89 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' THR . . . . . 0.411 HG21 ' OE2' ' A' ' 232' ' ' GLU . 28.2 m -93.61 163.98 13.34 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 120.737 -1.227 . . . . 3.24 109.336 -178.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.61 HG13 ' HA ' ' A' ' 193' ' ' ASP . 1.3 mp -157.77 139.27 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 N-CA-C 108.131 -1.062 . . . . 2.81 108.131 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . 0.837 ' CD2' ' CG ' ' A' ' 232' ' ' GLU . 22.6 m-85 -122.56 101.74 7.66 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.334 -0.946 . . . . 3.27 109.738 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.867 ' CB ' HG13 ' A' ' 233' ' ' VAL . 4.2 tt0 -73.82 83.95 1.66 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 103.918 -2.623 . . . . 1.78 103.918 175.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.789 ' CZ ' ' HB2' ' A' ' 240' ' ' ASP . 7.4 t80 -73.65 88.55 1.71 Allowed 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 105.69 -1.967 . . . . 2.48 105.69 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.905 ' C ' ' HA ' ' A' ' 235' ' ' CYS 0.26 10.0 m-20 -76.79 145.03 38.77 Favored 'General case' 0 C--N 1.257 -3.433 0 N-CA-C 106.409 -1.7 . . . . 1.83 106.409 179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.774 ' N ' ' SG ' ' A' ' 235' ' ' CYS . . . -107.24 114.71 4.38 Favored Glycine 0 N--CA 1.49 2.235 0 O-C-N 119.937 -1.727 . . . . 1.6 109.195 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.581 ' N ' HG22 ' A' ' 237' ' ' THR . 0.1 OUTLIER -59.15 -14.24 9.77 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.294 -1.121 . . . . 2.52 112.442 -179.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.938 ' HB2' ' CA ' ' A' ' 187' ' ' GLY . 31.1 mttt -75.61 -4.68 41.46 Favored 'General case' 0 CA--C 1.462 -2.423 0 O-C-N 120.863 -1.148 . . . . 4.32 110.126 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' SER . . . . . 0.751 ' CB ' ' O ' ' A' ' 187' ' ' GLY . 29.0 p -116.06 -179.63 3.72 Favored 'General case' 0 N--CA 1.4 -2.962 0 CA-C-O 124.379 2.038 . . . . 3.05 106.779 177.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.991 ' HB2' ' HD2' ' A' ' 208' ' ' PRO 0.28 0.0 OUTLIER -124.8 -158.94 0.04 OUTLIER Pre-proline 1 C--N 1.206 -5.66 0 CA-C-N 109.278 -3.601 . . . . 4.4 115.371 -164.628 . . . . . . . . 5 4 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . 0.991 ' HD2' ' HB2' ' A' ' 207' ' ' SER . 27.9 Cg_endo -61.32 -13.17 27.21 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 122.454 2.103 . . . . 3.27 112.376 -175.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.938 ' HB3' ' HB3' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -65.84 -72.87 0.14 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.848 -1.157 . . . . 3.87 109.614 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . 0.689 ' O ' HG23 ' A' ' 166' ' ' ILE . 1.5 pm0 -66.62 -32.4 73.71 Favored 'General case' 0 C--O 1.199 -1.594 0 N-CA-C 108.389 -0.967 . . . . 2.54 108.389 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.513 ' HB2' ' O ' ' A' ' 207' ' ' SER . 40.7 tttt -60.61 -43.97 96.84 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 117.92 -1.512 . . . . 3.97 110.238 -178.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 208' ' ' PRO . 23.9 t-20 -71.34 -51.67 22.97 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.083 -1.08 . . . . 3.63 108.083 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.739 ' HG2' HG13 ' A' ' 174' ' ' VAL . 2.4 tppt? -54.6 -42.71 71.45 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.721 -0.672 . . . . 3.94 110.561 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.635 ' HA ' HG13 ' A' ' 166' ' ' ILE . . . -69.26 -50.82 43.48 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.445 -0.946 . . . . 2.05 108.445 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 219' ' ' ARG . . . -51.69 -36.86 48.3 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 107.877 -1.157 . . . . 2.64 107.877 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -67.14 -46.57 73.67 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 109.172 -0.677 . . . . 3.97 109.172 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.851 HG11 HD13 ' A' ' 221' ' ' ILE . 57.6 t -62.22 -51.85 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.588 -0.523 . . . . 2.73 109.588 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -56.99 -31.39 65.03 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.816 -1.179 . . . . 2.53 107.816 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 215' ' ' ALA . 1.7 ttt180 -65.94 -54.81 21.59 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.364 -0.834 . . . . 5.53 112.551 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.28 -40.49 74.34 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 108.072 -1.084 . . . . 3.46 108.072 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.851 HD13 HG11 ' A' ' 217' ' ' VAL . 9.9 mt -70.77 -30.28 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.324 0.583 . . . . 3.11 109.562 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -67.09 -42.05 85.25 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.995 -1.113 . . . . 3.51 107.995 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.56 ' O ' ' HE3' ' A' ' 226' ' ' LYS . . . -75.11 -27.64 59.91 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.583 -0.525 . . . . 4.09 109.583 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -76.0 -47.06 26.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.049 -1.032 . . . . 4.39 110.092 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.755 ' HD3' ' HG3' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -93.45 -16.9 24.05 Favored 'General case' 0 N--CA 1.507 2.424 0 C-N-CA 120.211 -0.595 . . . . 4.47 111.86 -178.491 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.58 ' HD2' ' N ' ' A' ' 226' ' ' LYS . 0.0 OUTLIER 67.86 30.74 6.08 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.431 -0.951 . . . . 4.92 108.431 -178.189 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 68.94 2.69 31.92 Favored Glycine 0 CA--C 1.55 2.26 0 C-N-CA 118.386 -1.864 . . . . 3.26 109.608 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.748 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 0.6 OUTLIER -48.03 -50.31 55.15 Favored Pre-proline 0 N--CA 1.488 1.455 0 CA-C-N 119.659 1.729 . . . . 4.75 109.318 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.755 ' HG3' ' HD3' ' A' ' 225' ' ' ARG . 36.4 Cg_endo -77.84 165.85 26.01 Favored 'Trans proline' 0 N--CA 1.443 -1.45 0 O-C-N 124.168 1.615 . . . . 3.33 108.651 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -90.24 132.87 35.27 Favored 'General case' 0 C--N 1.271 -2.839 0 CA-C-N 115.334 -0.848 . . . . 4.24 111.12 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 1.6 t -124.21 151.52 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.724 0.773 . . . . 2.7 111.39 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.837 ' CG ' ' CD2' ' A' ' 199' ' ' TYR . 0.2 OUTLIER -138.36 101.09 4.29 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.038 -1.467 . . . . 2.97 107.038 177.388 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . 0.867 HG13 ' CB ' ' A' ' 200' ' ' GLN . 18.9 m -106.52 139.91 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.109 -0.995 . . . . 2.66 110.281 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.778 ' C ' ' HB2' ' A' ' 202' ' ' ASN . 0.1 OUTLIER -171.38 117.72 0.44 Allowed 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.568 -0.901 . . . . 2.6 108.568 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' CYS . . . . . 0.905 ' HA ' ' C ' ' A' ' 202' ' ' ASN . 0.1 OUTLIER -91.46 78.64 5.63 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.2 -1.778 . . . . 1.66 106.2 179.54 -127.066 114.616 -152.368 110.35 2.062 116.264 4.406 -84.611 3 3 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLU . . . . . 0.539 ' HG3' ' N ' ' A' ' 237' ' ' THR . 4.1 tp10 -104.95 161.66 14.01 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 112.799 -2.0 . . . . 3.02 111.311 -175.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.724 ' CG2' ' HG3' ' A' ' 205' ' ' LYS . 2.8 p -135.73 -64.98 0.61 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.239 -0.913 . . . . 2.36 112.739 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . 0.425 ' O ' ' HB3' ' A' ' 239' ' ' SER . 0.1 OUTLIER -66.89 137.97 56.96 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 120.133 -1.604 . . . . 3.25 107.933 -179.36 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' SER . . . . . 0.518 ' C ' ' H ' ' A' ' 241' ' ' ILE . 25.8 t 54.96 18.35 2.2 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 118.137 -1.425 . . . . 3.25 107.374 -177.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ASP . . . . . 0.789 ' HB2' ' CZ ' ' A' ' 201' ' ' PHE . 2.6 p30 -65.18 21.96 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.138 0 O-C-N 120.497 -1.377 . . . . 2.11 110.769 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ILE . . . . . 0.99 HG21 ' CG ' ' A' ' 246' ' ' TRP . 4.0 mp -127.28 77.21 75.87 Favored Pre-proline 0 C--N 1.305 -1.349 0 O-C-N 120.671 -1.268 . . . . 3.08 111.664 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.539 ' HD2' ' HE1' ' A' ' 246' ' ' TRP . 28.9 Cg_endo -73.39 116.1 4.57 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 N-CA-C 106.647 -2.097 . . . . 2.58 106.647 176.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . 0.647 ' O ' ' CB ' ' A' ' 247' ' ' LYS . . . -37.01 -31.51 0.03 OUTLIER 'General case' 0 C--O 1.181 -2.511 0 CA-C-N 116.054 -0.521 . . . . 3.5 110.651 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 242' ' ' PRO . 0.2 OUTLIER -56.67 -58.75 6.75 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 120.879 -1.138 . . . . 3.4 112.65 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . 0.727 ' HE1' ' CD2' ' A' ' 249' ' ' LEU . 0.1 OUTLIER -71.58 -45.22 62.83 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.648 0.737 . . . . 2.71 109.674 -178.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' TRP . . . . . 0.99 ' CG ' HG21 ' A' ' 241' ' ' ILE . 76.5 m95 -66.35 -27.87 68.22 Favored 'General case' 0 CA--C 1.462 -2.422 0 O-C-N 122.006 -0.434 . . . . 2.74 110.06 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . 0.647 ' CB ' ' O ' ' A' ' 243' ' ' ALA . 15.2 tttt -78.93 -46.43 18.4 Favored 'General case' 0 C--N 1.27 -2.88 0 N-CA-C 108.201 -1.037 . . . . 5.29 108.201 177.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.35 -42.63 70.49 Favored 'General case' 0 C--O 1.203 -1.366 0 CA-C-N 116.008 -0.542 . . . . 3.39 112.365 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.821 ' CD2' HD12 ' A' ' 163' ' ' LEU . 0.2 OUTLIER -109.07 -29.07 8.73 Favored 'General case' 0 CA--C 1.567 1.616 0 O-C-N 123.799 0.687 . . . . 2.96 109.819 -179.377 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . 0.907 ' HA3' HG23 ' A' ' 181' ' ' THR . . . -105.86 -40.0 2.07 Favored Glycine 1 N--CA 1.541 5.647 0 N-CA-C 115.511 0.964 . . . . 3.32 115.511 -179.327 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 246' ' ' TRP . . . . . . . . 1 N--CA 1.521 4.357 1 N-CA-C 96.816 -6.514 . . . . 3.7 96.816 168.595 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 . . . . . 2 N--CA 1.298 -8.067 1 N-CA-C 91.558 -7.201 . . . . 6.3200000000000003 91.558 . . . . . . . . . 2 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.642 ' HB3' ' CA ' ' A' ' 195' ' ' GLY 0.298 3.7 m-85 -84.81 157.12 21.06 Favored 'General case' 3 C--N 1.126 -9.132 1 N-CA-C 99.492 -4.262 . . . . 6.1900000000000004 99.492 -170.619 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -105.02 115.99 61.43 Favored Pre-proline 3 C--N 1.166 -7.389 0 CA-C-N 110.673 -2.967 . . . . 6.0999999999999996 104.013 -173.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 193' ' ' ASP . 30.6 Cg_endo -68.13 161.11 45.84 Favored 'Trans proline' 2 N--CA 1.373 -5.597 0 N-CA-C 102.704 -3.614 . . . . 3.3399999999999999 102.704 -178.709 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.721 ' C ' HD22 ' A' ' 163' ' ' LEU . 6.0 mtp180 -147.64 144.97 28.78 Favored 'General case' 1 C--N 1.236 -4.33 0 N-CA-C 105.567 -2.012 . . . . 4.29 105.567 -178.683 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 1.02 ' CD1' HD22 ' A' ' 249' ' ' LEU . 3.4 mm? -113.96 104.6 12.32 Favored 'General case' 0 C--N 1.268 -2.942 0 C-N-CA 118.28 -1.368 . . . . 2.6200000000000001 108.366 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.952 HD13 ' N ' ' A' ' 165' ' ' HIS . 2.2 tm? -98.87 138.7 35.62 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 104.764 -2.31 . . . . 2.3199999999999998 104.764 177.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.952 ' N ' HD13 ' A' ' 164' ' ' LEU . 21.5 t-160 -119.93 135.74 54.78 Favored 'General case' 0 C--N 1.282 -2.333 0 C-N-CA 120.131 -0.628 . . . . 2.0 110.355 -176.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.951 HD11 HD12 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -121.37 96.81 4.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.041 -1.096 . . . . 1.77 108.041 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.696 ' HB2' ' CB ' ' A' ' 188' ' ' ASP . 4.4 p -179.45 170.62 1.33 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 123.274 1.511 . . . . 2.4300000000000002 113.257 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.467 ' O ' ' C ' ' A' ' 169' ' ' ASP . . . 166.25 47.16 0.02 OUTLIER Glycine 0 C--N 1.281 -2.483 0 N-CA-C 109.743 -1.343 . . . . 3.1499999999999999 109.743 176.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 168' ' ' GLY . 54.3 m-20 41.99 -121.08 0.54 Allowed 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 119.498 1.649 . . . . 3.4500000000000002 107.268 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.21 -23.26 28.36 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.321 -0.951 . . . . 5.1500000000000004 111.623 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.597 ' O ' ' HG2' ' A' ' 173' ' ' LYS . 4.2 t-20 -96.06 74.78 3.03 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.567 -2.012 . . . . 4.6299999999999999 105.567 176.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 1.053 ' HB2' ' HB3' ' A' ' 209' ' ' GLN . . . -60.34 135.38 57.72 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 122.174 0.988 . . . . 3.1899999999999999 109.458 -177.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.603 ' HG2' ' C ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -153.67 139.03 17.58 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 104.891 -2.263 . . . . 4.4900000000000002 104.891 -177.379 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.952 HG11 ' HG3' ' A' ' 213' ' ' LYS . 1.5 p -131.12 151.24 35.51 Favored 'Isoleucine or valine' 1 C--N 1.233 -4.485 0 N-CA-C 107.074 -1.454 . . . . 2.7799999999999998 107.074 -176.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.555 ' O ' HD22 ' A' ' 164' ' ' LEU . . . -177.31 164.23 2.13 Favored 'General case' 0 C--N 1.275 -2.637 0 C-N-CA 118.7 -1.2 . . . . 2.8100000000000001 110.685 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.571 ' HA ' ' CD2' ' A' ' 164' ' ' LEU . 35.5 tt0 -60.55 147.4 41.64 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.71 0.766 . . . . 3.75 109.174 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.945 HG13 ' O ' ' A' ' 163' ' ' LEU . 0.5 OUTLIER -146.89 155.24 47.84 Favored Pre-proline 0 C--N 1.285 -2.214 0 N-CA-C 108.299 -1.0 . . . . 2.7000000000000002 108.299 179.773 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.559 ' O ' ' HB2' ' A' ' 163' ' ' LEU . 29.9 Cg_endo -71.76 175.65 9.34 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.388 2.059 . . . . 3.0099999999999998 108.208 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.943 ' HA ' ' HG ' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -54.86 143.19 26.63 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.564 -1.335 . . . . 4.2300000000000004 108.825 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.893 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -165.34 95.72 0.66 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.392 -1.323 . . . . 2.9199999999999999 111.817 175.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.994 HG21 ' HA3' ' A' ' 250' ' ' GLY . 0.2 OUTLIER -90.6 -50.96 5.63 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 105.233 -2.136 . . . . 3.5 105.233 176.246 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.5 -52.37 32.96 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.805 1.242 . . . . 3.1400000000000001 109.902 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.598 ' HB3' ' HB1' ' A' ' 180' ' ' ALA . 41.7 t -75.59 7.48 3.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.708 -0.62 . . . . 2.8399999999999999 110.431 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 180' ' ' ALA . 0.3 OUTLIER -55.01 -176.36 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.703 1.138 . . . . 2.1499999999999999 108.857 179.242 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.581 HD22 ' HE2' ' A' ' 190' ' ' PHE . 0.6 OUTLIER -141.3 78.68 1.65 Allowed 'General case' 0 C--N 1.27 -2.851 0 N-CA-C 107.917 -1.142 . . . . 1.8799999999999999 107.917 -178.481 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 39.9 t -55.04 141.29 34.82 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 106.785 -1.561 . . . . 2.0899999999999999 106.785 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.985 ' CA ' ' HB2' ' A' ' 205' ' ' LYS . . . 106.88 -33.69 6.24 Favored Glycine 1 C--O 1.141 -5.673 0 CA-C-O 117.625 -1.653 . . . . 1.9399999999999999 109.258 -178.759 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASP . . . . . 0.757 ' HA ' ' OG ' ' A' ' 206' ' ' SER . 0.1 OUTLIER -105.16 173.37 6.33 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 121.366 2.583 . . . . 2.2200000000000002 108.045 177.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 189' ' ' CYS . . . . . 0.933 ' HA ' ' HA ' ' A' ' 202' ' ' ASN . 7.5 m -87.85 142.58 27.7 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 117.152 -1.819 . . . . 1.27 107.209 -175.436 -84.611 4.406 -152.368 116.264 2.062 110.35 114.616 -127.066 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.581 ' HE2' HD22 ' A' ' 185' ' ' ASN . 1.7 t80 -131.97 158.09 42.37 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.69 0.757 . . . . 1.8700000000000001 108.97 -176.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.685 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 1.3 tp -144.0 118.13 9.5 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.11 -0.7 . . . . 1.74 109.11 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.958 ' C ' HD12 ' A' ' 192' ' ' LEU . 0.2 OUTLIER -109.95 137.59 47.51 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.455 -2.054 . . . . 2.1299999999999999 105.455 174.751 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.656 ' HA ' HG13 ' A' ' 198' ' ' ILE . 26.5 t0 -107.68 131.64 54.19 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.514 -1.291 . . . . 3.0600000000000001 107.514 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -135.21 98.16 3.91 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.818 -0.808 . . . . 2.9199999999999999 108.818 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.642 ' CA ' ' HB3' ' A' ' 159' ' ' TYR . . . 49.18 -108.18 0.39 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.852 -1.299 . . . . 3.29 109.852 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.545 ' O ' ' HB2' ' A' ' 229' ' ' PRO . 12.2 mt -93.32 -23.11 18.59 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 122.212 -0.581 . . . . 3.75 111.89 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' THR . . . . . 0.573 ' C ' HD12 ' A' ' 198' ' ' ILE . 28.2 m -93.61 163.98 13.34 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 120.737 -1.227 . . . . 2.9100000000000001 109.336 -178.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.656 HG13 ' HA ' ' A' ' 193' ' ' ASP . 1.3 mp -157.77 139.27 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 N-CA-C 108.131 -1.062 . . . . 2.3900000000000001 108.131 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' TYR . . . . . 0.837 ' CD2' ' CG ' ' A' ' 232' ' ' GLU . 22.6 m-85 -122.56 101.74 7.66 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.334 -0.946 . . . . 2.6600000000000001 109.738 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 1.036 ' CB ' HG12 ' A' ' 233' ' ' VAL . 2.7 tt0 -73.82 83.95 1.66 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 103.918 -2.623 . . . . 1.78 103.918 175.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.813 ' CZ ' ' HB2' ' A' ' 240' ' ' ASP . 7.4 t80 -73.65 88.55 1.71 Allowed 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 105.69 -1.967 . . . . 1.74 105.69 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.968 ' C ' ' HA ' ' A' ' 235' ' ' CYS 0.26 10.0 m-20 -76.79 145.03 38.77 Favored 'General case' 0 C--N 1.257 -3.433 0 N-CA-C 106.409 -1.7 . . . . 1.3999999999999999 106.409 179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.774 ' N ' ' SG ' ' A' ' 235' ' ' CYS . . . -107.24 114.71 4.38 Favored Glycine 0 N--CA 1.49 2.235 0 O-C-N 119.937 -1.727 . . . . 1.6000000000000001 109.195 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.599 ' N ' HG23 ' A' ' 237' ' ' THR . 0.1 OUTLIER -59.15 -14.24 9.77 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.294 -1.121 . . . . 2.29 112.442 -179.466 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.985 ' HB2' ' CA ' ' A' ' 187' ' ' GLY . 31.1 mttt -75.61 -4.68 41.46 Favored 'General case' 0 CA--C 1.462 -2.423 0 O-C-N 120.863 -1.148 . . . . 3.9100000000000001 110.126 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' SER . . . . . 0.757 ' OG ' ' HA ' ' A' ' 188' ' ' ASP . 29.0 p -116.06 -179.63 3.72 Favored 'General case' 0 N--CA 1.4 -2.962 0 CA-C-O 124.379 2.038 . . . . 2.7200000000000002 106.779 177.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . 1.063 ' HB2' ' HD2' ' A' ' 208' ' ' PRO 0.28 0.0 OUTLIER -124.8 -158.94 0.04 OUTLIER Pre-proline 1 C--N 1.206 -5.66 0 CA-C-N 109.278 -3.601 . . . . 3.9900000000000002 115.371 -164.628 . . . . . . . . 5 4 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PRO . . . . . 1.063 ' HD2' ' HB2' ' A' ' 207' ' ' SER . 27.9 Cg_endo -61.32 -13.17 27.21 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 122.454 2.103 . . . . 3.1099999999999999 112.376 -175.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 1.053 ' HB3' ' HB2' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -65.84 -72.87 0.14 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.848 -1.157 . . . . 3.5099999999999998 109.614 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLU . . . . . 0.655 ' HA ' HG22 ' A' ' 166' ' ' ILE . 1.5 pm0 -66.62 -32.4 73.71 Favored 'General case' 0 C--O 1.199 -1.594 0 N-CA-C 108.389 -0.967 . . . . 2.54 108.389 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.538 ' HB2' ' O ' ' A' ' 207' ' ' SER . 40.7 tttt -60.61 -43.97 96.84 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 117.92 -1.512 . . . . 3.5699999999999998 110.238 -178.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 208' ' ' PRO . 23.9 t-20 -71.34 -51.67 22.97 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.083 -1.08 . . . . 3.48 108.083 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.952 ' HG3' HG11 ' A' ' 174' ' ' VAL . 2.4 tppt? -54.6 -42.71 71.45 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.721 -0.672 . . . . 3.6000000000000001 110.561 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.776 ' HB2' HG21 ' A' ' 166' ' ' ILE . . . -69.26 -50.82 43.48 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.445 -0.946 . . . . 2.0499999999999998 108.445 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 219' ' ' ARG . . . -51.69 -36.86 48.3 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 107.877 -1.157 . . . . 2.4900000000000002 107.877 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -67.14 -46.57 73.67 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 109.172 -0.677 . . . . 3.9700000000000002 109.172 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 213' ' ' LYS . 57.6 t -62.22 -51.85 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.588 -0.523 . . . . 2.5 109.588 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.674 ' HB2' ' NE2' ' A' ' 200' ' ' GLN . . . -56.99 -31.39 65.03 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.816 -1.179 . . . . 2.5299999999999998 107.816 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 215' ' ' ALA . 1.7 ttt180 -65.94 -54.81 21.59 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.364 -0.834 . . . . 5.0199999999999996 112.551 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.28 -40.49 74.34 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 108.072 -1.084 . . . . 3.3399999999999999 108.072 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.675 HD11 HG12 ' A' ' 217' ' ' VAL . 9.9 mt -70.77 -30.28 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.324 0.583 . . . . 3.0499999999999998 109.562 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -67.09 -42.05 85.25 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.995 -1.113 . . . . 3.5099999999999998 107.995 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.562 ' O ' ' HE3' ' A' ' 226' ' ' LYS . . . -75.11 -27.64 59.91 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.583 -0.525 . . . . 3.9100000000000001 109.583 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -76.0 -47.06 26.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.049 -1.032 . . . . 4.3899999999999997 110.092 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.784 ' HD3' ' HG3' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -93.45 -16.9 24.05 Favored 'General case' 0 N--CA 1.507 2.424 0 C-N-CA 120.211 -0.595 . . . . 4.1299999999999999 111.86 -178.491 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.598 ' HD2' ' N ' ' A' ' 226' ' ' LYS . 0.0 OUTLIER 67.86 30.74 6.08 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.431 -0.951 . . . . 4.6299999999999999 108.431 -178.189 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 68.94 2.69 31.92 Favored Glycine 0 CA--C 1.55 2.26 0 C-N-CA 118.386 -1.864 . . . . 3.2599999999999998 109.608 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.761 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 0.6 OUTLIER -48.03 -50.31 55.15 Favored Pre-proline 0 N--CA 1.488 1.455 0 CA-C-N 119.659 1.729 . . . . 4.2999999999999998 109.318 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.784 ' HG3' ' HD3' ' A' ' 225' ' ' ARG . 36.4 Cg_endo -77.84 165.85 26.01 Favored 'Trans proline' 0 N--CA 1.443 -1.45 0 O-C-N 124.168 1.615 . . . . 3.2200000000000002 108.651 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' LYS . . . . . 0.414 ' HB3' HG23 ' A' ' 197' ' ' THR . 19.3 tttt -90.24 132.87 35.27 Favored 'General case' 0 C--N 1.271 -2.839 0 CA-C-N 115.334 -0.848 . . . . 3.9500000000000002 111.12 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 1.6 t -124.21 151.52 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.724 0.773 . . . . 2.3799999999999999 111.39 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLU . . . . . 0.837 ' CG ' ' CD2' ' A' ' 199' ' ' TYR . 0.2 OUTLIER -138.36 101.09 4.29 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.038 -1.467 . . . . 2.9700000000000002 107.038 177.388 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 233' ' ' VAL . . . . . 1.036 HG12 ' CB ' ' A' ' 200' ' ' GLN . 18.9 m -106.52 139.91 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.109 -0.995 . . . . 2.1200000000000001 110.281 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.848 ' C ' ' HB2' ' A' ' 202' ' ' ASN . 0.1 OUTLIER -171.38 117.72 0.44 Allowed 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.568 -0.901 . . . . 1.8899999999999999 108.568 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 235' ' ' CYS . . . . . 0.968 ' HA ' ' C ' ' A' ' 202' ' ' ASN . 0.1 OUTLIER -91.46 78.64 5.63 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.2 -1.778 . . . . 1.6599999999999999 106.2 179.54 -127.066 114.616 -152.368 110.35 2.062 116.264 4.406 -84.611 3 3 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLU . . . . . 0.545 ' HG3' ' N ' ' A' ' 237' ' ' THR . 4.1 tp10 -104.95 161.66 14.01 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 112.799 -2.0 . . . . 3.02 111.311 -175.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.754 ' CG2' ' HG3' ' A' ' 205' ' ' LYS . 2.8 p -135.73 -64.98 0.61 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.239 -0.913 . . . . 2.1699999999999999 112.739 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 239' ' ' SER . 0.1 OUTLIER -66.89 137.97 56.96 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 120.133 -1.604 . . . . 3.25 107.933 -179.36 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 239' ' ' SER . . . . . 0.514 ' C ' ' H ' ' A' ' 241' ' ' ILE . 25.8 t 54.96 18.35 2.2 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 118.137 -1.425 . . . . 3.0099999999999998 107.374 -177.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ASP . . . . . 0.813 ' HB2' ' CZ ' ' A' ' 201' ' ' PHE . 2.6 p30 -65.18 21.96 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.138 0 O-C-N 120.497 -1.377 . . . . 2.1000000000000001 110.769 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ILE . . . . . 1.124 HG23 ' CD2' ' A' ' 246' ' ' TRP . 4.0 mp -127.28 77.21 75.87 Favored Pre-proline 0 C--N 1.305 -1.349 0 O-C-N 120.671 -1.268 . . . . 2.79 111.664 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.592 ' HD2' ' HE1' ' A' ' 246' ' ' TRP . 28.9 Cg_endo -73.39 116.1 4.57 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 N-CA-C 106.647 -2.097 . . . . 2.5099999999999998 106.647 176.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' A' ' 247' ' ' LYS . . . -37.01 -31.51 0.03 OUTLIER 'General case' 0 C--O 1.181 -2.511 0 CA-C-N 116.054 -0.521 . . . . 3.1699999999999999 110.651 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 242' ' ' PRO . 0.2 OUTLIER -56.67 -58.75 6.75 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 120.879 -1.138 . . . . 3.3999999999999999 112.65 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 245' ' ' PHE . . . . . 1.043 ' HE1' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -71.58 -45.22 62.83 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.648 0.737 . . . . 2.3300000000000001 109.674 -178.394 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 246' ' ' TRP . . . . . 1.124 ' CD2' HG23 ' A' ' 241' ' ' ILE . 76.5 m95 -66.35 -27.87 68.22 Favored 'General case' 0 CA--C 1.462 -2.422 0 O-C-N 122.006 -0.434 . . . . 2.7400000000000002 110.06 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LYS . . . . . 0.662 ' HA ' ' H ' ' A' ' 251' ' ' GLY . 15.2 tttt -78.93 -46.43 18.4 Favored 'General case' 0 C--N 1.27 -2.88 0 N-CA-C 108.201 -1.037 . . . . 4.9000000000000004 108.201 177.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.52 HD13 ' HE1' ' A' ' 199' ' ' TYR . 0.3 OUTLIER -54.35 -42.63 70.49 Favored 'General case' 0 C--O 1.203 -1.366 0 CA-C-N 116.008 -0.542 . . . . 3.0699999999999998 112.365 -177.706 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 1.043 HD23 ' HE1' ' A' ' 245' ' ' PHE . 0.2 OUTLIER -109.07 -29.07 8.73 Favored 'General case' 0 CA--C 1.567 1.616 0 O-C-N 123.799 0.687 . . . . 2.9199999999999999 109.819 -179.377 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 250' ' ' GLY . . . . . 0.994 ' HA3' HG21 ' A' ' 181' ' ' THR . . . -105.86 -40.0 2.07 Favored Glycine 1 N--CA 1.541 5.647 0 N-CA-C 115.511 0.964 . . . . 3.3199999999999998 115.511 -179.327 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.662 ' H ' ' HA ' ' A' ' 247' ' ' LYS . . . . . . . . 1 N--CA 1.521 4.357 1 N-CA-C 96.816 -6.514 . . . . 3.7000000000000002 96.816 168.595 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 . . . . . 2 N--CA 1.298 -8.067 1 N-CA-C 91.558 -7.201 . . . . 6.32 91.558 . . . . . . . . . 2 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.642 ' HB3' ' CA ' ' A' ' 195' ' ' GLY 0.298 3.7 m-85 -84.81 157.12 21.06 Favored 'General case' 3 C--N 1.126 -9.132 1 N-CA-C 99.492 -4.262 . . . . 6.19 99.492 -170.619 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -105.02 115.99 61.43 Favored Pre-proline 3 C--N 1.166 -7.389 0 CA-C-N 110.673 -2.967 . . . . 6.1 104.013 -173.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 193' ' ' ASP . 30.6 Cg_endo -68.13 161.11 45.84 Favored 'Trans proline' 2 N--CA 1.373 -5.597 0 N-CA-C 102.704 -3.614 . . . . 3.34 102.704 -178.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.721 ' C ' HD22 ' A' ' 163' ' ' LEU . 6.0 mtp180 -147.64 144.97 28.78 Favored 'General case' 1 C--N 1.236 -4.33 0 N-CA-C 105.567 -2.012 . . . . 4.29 105.567 -178.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 1.02 ' CD1' HD22 ' A' ' 249' ' ' LEU . 3.4 mm? -113.96 104.6 12.32 Favored 'General case' 0 C--N 1.268 -2.942 0 C-N-CA 118.28 -1.368 . . . . 2.62 108.366 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.952 HD13 ' N ' ' A' ' 165' ' ' HIS . 2.2 tm? -98.87 138.7 35.62 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 104.764 -2.31 . . . . 2.32 104.764 177.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.952 ' N ' HD13 ' A' ' 164' ' ' LEU . 21.5 t-160 -119.93 135.74 54.78 Favored 'General case' 0 C--N 1.282 -2.333 0 C-N-CA 120.131 -0.628 . . . . 2.0 110.355 -176.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.951 HD11 HD12 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -121.37 96.81 4.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.041 -1.096 . . . . 1.77 108.041 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.696 ' HB2' ' CB ' ' A' ' 188' ' ' ASP . 4.4 p -179.45 170.62 1.33 Allowed 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 123.274 1.511 . . . . 2.43 113.257 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.467 ' O ' ' C ' ' A' ' 169' ' ' ASP . . . 166.25 47.16 0.02 OUTLIER Glycine 0 C--N 1.281 -2.483 0 N-CA-C 109.743 -1.343 . . . . 3.15 109.743 176.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 168' ' ' GLY . 54.3 m-20 41.99 -121.08 0.54 Allowed 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 119.498 1.649 . . . . 3.45 107.268 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.21 -23.26 28.36 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.321 -0.951 . . . . 5.15 111.623 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.597 ' O ' ' HG2' ' A' ' 173' ' ' LYS . 4.2 t-20 -96.06 74.78 3.03 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.567 -2.012 . . . . 4.63 105.567 176.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 1.053 ' HB2' ' HB3' ' A' ' 209' ' ' GLN . . . -60.34 135.38 57.72 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 122.174 0.988 . . . . 3.19 109.458 -177.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.603 ' HG2' ' C ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -153.67 139.03 17.58 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 104.891 -2.263 . . . . 4.49 104.891 -177.379 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.952 HG11 ' HG3' ' A' ' 213' ' ' LYS . 1.5 p -131.12 151.24 35.51 Favored 'Isoleucine or valine' 1 C--N 1.233 -4.485 0 N-CA-C 107.074 -1.454 . . . . 2.78 107.074 -176.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.555 ' O ' HD22 ' A' ' 164' ' ' LEU . . . -177.31 164.23 2.13 Favored 'General case' 0 C--N 1.275 -2.637 0 C-N-CA 118.7 -1.2 . . . . 2.81 110.685 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.571 ' HA ' ' CD2' ' A' ' 164' ' ' LEU . 35.5 tt0 -60.55 147.4 41.64 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.71 0.766 . . . . 3.75 109.174 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.945 HG13 ' O ' ' A' ' 163' ' ' LEU . 0.5 OUTLIER -146.89 155.24 47.84 Favored Pre-proline 0 C--N 1.285 -2.214 0 N-CA-C 108.299 -1.0 . . . . 2.7 108.299 179.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.559 ' O ' ' HB2' ' A' ' 163' ' ' LEU . 29.9 Cg_endo -71.76 175.65 9.34 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.388 2.059 . . . . 3.01 108.208 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.943 ' HA ' ' HG ' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -54.86 143.19 26.63 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.564 -1.335 . . . . 4.23 108.825 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.893 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -165.34 95.72 0.66 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.392 -1.323 . . . . 2.92 111.817 175.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.994 HG21 ' HA3' ' A' ' 250' ' ' GLY . 0.2 OUTLIER -90.6 -50.96 5.63 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 105.233 -2.136 . . . . 3.5 105.233 176.246 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.5 -52.37 32.96 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.805 1.242 . . . . 3.14 109.902 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.598 ' HB3' ' HB1' ' A' ' 180' ' ' ALA . 41.7 t -75.59 7.48 3.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.708 -0.62 . . . . 2.84 110.431 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 180' ' ' ALA . 0.3 OUTLIER -55.01 -176.36 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.703 1.138 . . . . 2.15 108.857 179.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.594 ' ND2' ' NE2' ' A' ' 165' ' ' HIS . 1.5 p-10 -141.3 78.68 1.65 Allowed 'General case' 0 C--N 1.27 -2.851 0 N-CA-C 107.917 -1.142 . . . . 1.88 107.917 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 39.9 t -55.04 141.29 34.82 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 106.785 -1.561 . . . . 2.09 106.785 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.985 ' CA ' ' HB2' ' A' ' 205' ' ' LYS . . . 106.88 -33.69 6.24 Favored Glycine 1 C--O 1.141 -5.673 0 CA-C-O 117.625 -1.653 . . . . 1.94 109.258 -178.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . 0.757 ' HA ' ' OG ' ' A' ' 206' ' ' SER . 0.1 OUTLIER -105.16 173.37 6.33 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 121.366 2.583 . . . . 2.22 108.045 177.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' CYS . . . . . 0.933 ' HA ' ' HA ' ' A' ' 202' ' ' ASN . 7.5 m -87.85 142.58 27.7 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 117.152 -1.819 . . . . 1.27 107.209 -175.436 -84.611 4.406 -152.368 116.264 2.062 110.35 114.616 -127.066 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.477 ' CD1' ' O ' ' A' ' 164' ' ' LEU . 1.7 t80 -131.97 158.09 42.37 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.69 0.757 . . . . 1.87 108.97 -176.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.685 ' HA ' ' HA ' ' A' ' 200' ' ' GLN . 1.3 tp -144.0 118.13 9.5 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 109.11 -0.7 . . . . 1.74 109.11 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.958 HD12 ' C ' ' A' ' 192' ' ' LEU . 0.2 OUTLIER -109.95 137.59 47.51 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 105.455 -2.054 . . . . 2.13 105.455 174.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.656 ' HA ' HG13 ' A' ' 198' ' ' ILE . 26.5 t0 -107.68 131.64 54.19 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 107.514 -1.291 . . . . 3.06 107.514 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -135.21 98.16 3.91 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.818 -0.808 . . . . 2.92 108.818 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.642 ' CA ' ' HB3' ' A' ' 159' ' ' TYR . . . 49.18 -108.18 0.39 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.852 -1.299 . . . . 3.29 109.852 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.545 ' O ' ' HB2' ' A' ' 229' ' ' PRO . 12.2 mt -93.32 -23.11 18.59 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 122.212 -0.581 . . . . 3.75 111.89 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . 0.573 ' C ' HD12 ' A' ' 198' ' ' ILE . 28.2 m -93.61 163.98 13.34 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 120.737 -1.227 . . . . 2.91 109.336 -178.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.656 HG13 ' HA ' ' A' ' 193' ' ' ASP . 1.3 mp -157.77 139.27 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 N-CA-C 108.131 -1.062 . . . . 2.39 108.131 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . 0.837 ' CD2' ' CG ' ' A' ' 232' ' ' GLU . 22.6 m-85 -122.56 101.74 7.66 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.334 -0.946 . . . . 2.66 109.738 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 1.036 ' CB ' HG12 ' A' ' 233' ' ' VAL . 4.2 tt0 -73.82 83.95 1.66 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 103.918 -2.623 . . . . 1.78 103.918 175.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.813 ' CZ ' ' HB2' ' A' ' 240' ' ' ASP . 7.4 t80 -73.65 88.55 1.71 Allowed 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 105.69 -1.967 . . . . 1.74 105.69 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.968 ' C ' ' HA ' ' A' ' 235' ' ' CYS 0.26 10.0 m-20 -76.79 145.03 38.77 Favored 'General case' 0 C--N 1.257 -3.433 0 N-CA-C 106.409 -1.7 . . . . 1.4 106.409 179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.774 ' N ' ' SG ' ' A' ' 235' ' ' CYS . . . -107.24 114.71 4.38 Favored Glycine 0 N--CA 1.49 2.235 0 O-C-N 119.937 -1.727 . . . . 1.6 109.195 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.599 ' N ' HG23 ' A' ' 237' ' ' THR . 0.1 OUTLIER -59.15 -14.24 9.77 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.294 -1.121 . . . . 2.29 112.442 -179.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.985 ' HB2' ' CA ' ' A' ' 187' ' ' GLY . 31.1 mttt -75.61 -4.68 41.46 Favored 'General case' 0 CA--C 1.462 -2.423 0 O-C-N 120.863 -1.148 . . . . 3.91 110.126 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . 0.757 ' OG ' ' HA ' ' A' ' 188' ' ' ASP . 29.0 p -116.06 -179.63 3.72 Favored 'General case' 0 N--CA 1.4 -2.962 0 CA-C-O 124.379 2.038 . . . . 2.72 106.779 177.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 1.063 ' HB2' ' HD2' ' A' ' 208' ' ' PRO 0.28 0.0 OUTLIER -124.8 -158.94 0.04 OUTLIER Pre-proline 1 C--N 1.206 -5.66 0 CA-C-N 109.278 -3.601 . . . . 3.99 115.371 -164.628 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . 1.063 ' HD2' ' HB2' ' A' ' 207' ' ' SER . 27.9 Cg_endo -61.32 -13.17 27.21 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 122.454 2.103 . . . . 3.11 112.376 -175.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 1.053 ' HB3' ' HB2' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -65.84 -72.87 0.14 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.848 -1.157 . . . . 3.51 109.614 179.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . 0.655 ' HA ' HG22 ' A' ' 166' ' ' ILE . 1.5 pm0 -66.62 -32.4 73.71 Favored 'General case' 0 C--O 1.199 -1.594 0 N-CA-C 108.389 -0.967 . . . . 2.54 108.389 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.538 ' HB2' ' O ' ' A' ' 207' ' ' SER . 40.7 tttt -60.61 -43.97 96.84 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 117.92 -1.512 . . . . 3.57 110.238 -178.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 208' ' ' PRO . 23.9 t-20 -71.34 -51.67 22.97 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.083 -1.08 . . . . 3.48 108.083 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.952 ' HG3' HG11 ' A' ' 174' ' ' VAL . 2.4 tppt? -54.6 -42.71 71.45 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.721 -0.672 . . . . 3.6 110.561 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.792 ' HB1' ' NE2' ' A' ' 200' ' ' GLN . . . -69.26 -50.82 43.48 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.445 -0.946 . . . . 2.05 108.445 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 219' ' ' ARG . . . -51.69 -36.86 48.3 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 107.877 -1.157 . . . . 2.49 107.877 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -67.14 -46.57 73.67 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 109.172 -0.677 . . . . 3.97 109.172 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 213' ' ' LYS . 57.6 t -62.22 -51.85 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.588 -0.523 . . . . 2.5 109.588 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.556 ' HA ' HD12 ' A' ' 221' ' ' ILE . . . -56.99 -31.39 65.03 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.816 -1.179 . . . . 2.53 107.816 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 215' ' ' ALA . 1.7 ttt180 -65.94 -54.81 21.59 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.364 -0.834 . . . . 5.02 112.551 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -56.28 -40.49 74.34 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 108.072 -1.084 . . . . 3.34 108.072 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.675 HD11 HG12 ' A' ' 217' ' ' VAL . 9.9 mt -70.77 -30.28 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.324 0.583 . . . . 3.05 109.562 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -67.09 -42.05 85.25 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.995 -1.113 . . . . 3.51 107.995 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.562 ' O ' ' HE3' ' A' ' 226' ' ' LYS . . . -75.11 -27.64 59.91 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.583 -0.525 . . . . 3.91 109.583 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -76.0 -47.06 26.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.049 -1.032 . . . . 4.39 110.092 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.784 ' HD3' ' HG3' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -93.45 -16.9 24.05 Favored 'General case' 0 N--CA 1.507 2.424 0 C-N-CA 120.211 -0.595 . . . . 4.13 111.86 -178.491 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.598 ' HD2' ' N ' ' A' ' 226' ' ' LYS . 0.0 OUTLIER 67.86 30.74 6.08 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.431 -0.951 . . . . 4.63 108.431 -178.189 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . 68.94 2.69 31.92 Favored Glycine 0 CA--C 1.55 2.26 0 C-N-CA 118.386 -1.864 . . . . 3.26 109.608 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.761 ' HB3' ' HD3' ' A' ' 229' ' ' PRO . 0.6 OUTLIER -48.03 -50.31 55.15 Favored Pre-proline 0 N--CA 1.488 1.455 0 CA-C-N 119.659 1.729 . . . . 4.3 109.318 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.784 ' HG3' ' HD3' ' A' ' 225' ' ' ARG . 36.4 Cg_endo -77.84 165.85 26.01 Favored 'Trans proline' 0 N--CA 1.443 -1.45 0 O-C-N 124.168 1.615 . . . . 3.22 108.651 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' LYS . . . . . 0.414 ' HB3' HG23 ' A' ' 197' ' ' THR . 19.3 tttt -90.24 132.87 35.27 Favored 'General case' 0 C--N 1.271 -2.839 0 CA-C-N 115.334 -0.848 . . . . 3.95 111.12 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 1.6 t -124.21 151.52 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.724 0.773 . . . . 2.38 111.39 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . 0.837 ' CG ' ' CD2' ' A' ' 199' ' ' TYR . 0.2 OUTLIER -138.36 101.09 4.29 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.038 -1.467 . . . . 2.97 107.038 177.388 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . 1.036 HG12 ' CB ' ' A' ' 200' ' ' GLN . 18.9 m -106.52 139.91 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.109 -0.995 . . . . 2.12 110.281 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.848 ' C ' ' HB2' ' A' ' 202' ' ' ASN . 0.1 OUTLIER -171.38 117.72 0.44 Allowed 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 108.568 -0.901 . . . . 1.89 108.568 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' CYS . . . . . 0.968 ' HA ' ' C ' ' A' ' 202' ' ' ASN . 0.1 OUTLIER -91.46 78.64 5.63 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 106.2 -1.778 . . . . 1.66 106.2 179.54 -127.066 114.616 -152.368 110.35 2.062 116.264 4.406 -84.611 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLU . . . . . 0.545 ' HG3' ' N ' ' A' ' 237' ' ' THR . 4.1 tp10 -104.95 161.66 14.01 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 112.799 -2.0 . . . . 3.02 111.311 -175.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.754 ' CG2' ' HG3' ' A' ' 205' ' ' LYS . 2.8 p -135.73 -64.98 0.61 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.239 -0.913 . . . . 2.17 112.739 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 239' ' ' SER . 0.1 OUTLIER -66.89 137.97 56.96 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 120.133 -1.604 . . . . 3.25 107.933 -179.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . 0.514 ' C ' ' H ' ' A' ' 241' ' ' ILE . 25.8 t 54.96 18.35 2.2 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 118.137 -1.425 . . . . 3.01 107.374 -177.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ASP . . . . . 0.813 ' HB2' ' CZ ' ' A' ' 201' ' ' PHE . 2.6 p30 -65.18 21.96 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.138 0 O-C-N 120.497 -1.377 . . . . 2.1 110.769 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ILE . . . . . 1.124 HG23 ' CD2' ' A' ' 246' ' ' TRP . 4.0 mp -127.28 77.21 75.87 Favored Pre-proline 0 C--N 1.305 -1.349 0 O-C-N 120.671 -1.268 . . . . 2.79 111.664 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.592 ' HD2' ' HE1' ' A' ' 246' ' ' TRP . 28.9 Cg_endo -73.39 116.1 4.57 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 N-CA-C 106.647 -2.097 . . . . 2.51 106.647 176.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . 0.659 ' O ' ' HB2' ' A' ' 247' ' ' LYS . . . -37.01 -31.51 0.03 OUTLIER 'General case' 0 C--O 1.181 -2.511 0 CA-C-N 116.054 -0.521 . . . . 3.17 110.651 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 242' ' ' PRO . 0.2 OUTLIER -56.67 -58.75 6.75 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 120.879 -1.138 . . . . 3.4 112.65 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . 1.043 ' HE1' HD23 ' A' ' 249' ' ' LEU . 0.1 OUTLIER -71.58 -45.22 62.83 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.648 0.737 . . . . 2.33 109.674 -178.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' TRP . . . . . 1.124 ' CD2' HG23 ' A' ' 241' ' ' ILE . 76.5 m95 -66.35 -27.87 68.22 Favored 'General case' 0 CA--C 1.462 -2.422 0 O-C-N 122.006 -0.434 . . . . 2.74 110.06 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . 0.662 ' HA ' ' H ' ' A' ' 251' ' ' GLY . 15.2 tttt -78.93 -46.43 18.4 Favored 'General case' 0 C--N 1.27 -2.88 0 N-CA-C 108.201 -1.037 . . . . 4.9 108.201 177.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.52 HD13 ' HE1' ' A' ' 199' ' ' TYR . 0.3 OUTLIER -54.35 -42.63 70.49 Favored 'General case' 0 C--O 1.203 -1.366 0 CA-C-N 116.008 -0.542 . . . . 3.07 112.365 -177.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 1.043 HD23 ' HE1' ' A' ' 245' ' ' PHE . 0.2 OUTLIER -109.07 -29.07 8.73 Favored 'General case' 0 CA--C 1.567 1.616 0 O-C-N 123.799 0.687 . . . . 2.92 109.819 -179.377 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . 0.994 ' HA3' HG21 ' A' ' 181' ' ' THR . . . -105.86 -40.0 2.07 Favored Glycine 1 N--CA 1.541 5.647 0 N-CA-C 115.511 0.964 . . . . 3.32 115.511 -179.327 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.662 ' H ' ' HA ' ' A' ' 247' ' ' LYS . . . . . . . . 1 N--CA 1.521 4.357 1 N-CA-C 96.816 -6.514 . . . . 3.7 96.816 168.595 . . . . . . . . 3 2 . 1 stop_ save_